Scott Gottlieb and Luciana Borio, a former director for medical and biodefense preparedness policy at the National Security ...
HealthDay on MSN4d
FDA approves Gemtesa for overactive bladder in men with BPHGemtesa is approved for men with overactive bladder symptoms who are receiving pharmacologic treatment for benign prostatic hyperplasia.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback